Literature DB >> 34889441

How to manage bleeding disorders in aging patients needing surgery.

Mouhamed Yazan Abou-Ismail1, Nathan T Connell2,3.   

Abstract

With improvements in medical care, the life expectancy of patients with bleeding disorders is approaching that of the general population. A growing population of older adult patients with bleeding disorders is at risk of age-related comorbidities and in need of various elective and emergent age-related procedures. The increased risk of thrombosis and volume overload in older adults complicates perioperative hemostatic management. Furthermore, antithrombotic treatment such as antiplatelet or anticoagulant therapy, which is frequently required for various cardiovascular interventions, requires a meticulous individualized approach. Evidence-based guidelines for the management of aging patients with bleeding disorders are lacking, largely due to the underrepresentation of older adult patients in clinical trials as well as the rarity of many such bleeding disorders. We discuss the current guidelines and recommendations in the perioperative hemostatic management of older adult patients with hemophilia and von Willebrand disease as well as other rare bleeding disorders. The optimal management of these patients is often complex and requires a thorough multidisciplinary and individualized approach involving hematologists, surgeons, anesthesiologists, and the specialists treating the underlying disorder.
Copyright © 2021 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2021        PMID: 34889441      PMCID: PMC8791143          DOI: 10.1182/hematology.2021000288

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  67 in total

1.  Applicability of the European Society of Cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE Working Group.

Authors:  P Staritz; P de Moerloose; R Schutgens; G Dolan
Journal:  Haemophilia       Date:  2013-05-28       Impact factor: 4.287

2.  Increase of von Willebrand factor with aging in type 1 von Willebrand disease: fact or fiction?

Authors:  Mariachiara Borghi; Giuseppe Guglielmini; Anna Maria Mezzasoma; Emanuela Falcinelli; Loredana Bury; Marco Malvestiti; Paolo Gresele
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

3.  Management of severe factor XI deficiency in cardiac surgery: A case report and review of the literature.

Authors:  Nathan D Gay; Sharl Azar; Ophira Salomon; Jason A Taylor
Journal:  Haemophilia       Date:  2017-08-31       Impact factor: 4.287

Review 4.  Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.

Authors:  Antonio Coppola; Jerzy Windyga; Antonella Tufano; Cindy Yeung; Matteo Nicola Dario Di Minno
Journal:  Cochrane Database Syst Rev       Date:  2015-02-09

5.  Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single-centre experience.

Authors:  Oliver C Cohen; Michele Bertelli; Gavin Manmathan; Callum Little; Anne Riddell; Debra Pollard; Elsa Aradom; Molly Mussara; Chris Harrington; Pamela Kanagasabapathy; Ravi De Silva; Bruce Martin; Rita Peralta; Keith Gomez; Thynn Yee; Pratima Chowdary; Roby D Rakhit
Journal:  Haemophilia       Date:  2021-03-22       Impact factor: 4.287

Review 6.  Surgery in patients with inherited bleeding disorders.

Authors:  P K Mensah; R Gooding
Journal:  Anaesthesia       Date:  2015-01       Impact factor: 6.955

7.  Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.

Authors:  E Santagostino; M E Mancuso; A Tripodi; V Chantarangkul; M Clerici; I Garagiola; P M Mannucci
Journal:  J Thromb Haemost       Date:  2009-01-21       Impact factor: 5.824

8.  International recommendations on the diagnosis and treatment of acquired hemophilia A.

Authors:  Andreas Tiede; Peter Collins; Paul Knoebl; Jerome Teitel; Craig Kessler; Midori Shima; Giovanni Di Minno; Roseline d'Oiron; Peter Salaj; Victor Jiménez-Yuste; Angela Huth-Kühne; Paul Giangrande
Journal:  Haematologica       Date:  2020-05-07       Impact factor: 9.941

9.  Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).

Authors:  Madhvi Rajpurkar; Stacy E Croteau; Lisa Boggio; David L Cooper
Journal:  J Blood Med       Date:  2019-09-18

10.  Acquired von Willebrand syndrome in monoclonal gammopathy - A scoping review on hemostatic management.

Authors:  Mouhamed Yazan Abou-Ismail; George M Rodgers; Paul F Bray; Ming Y Lim
Journal:  Res Pract Thromb Haemost       Date:  2021-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.